PROFIL Institut für Stoffwechselforschung GmbH

🇩🇪Germany
Ownership
-
Employees
-
Market Cap
-
Website

Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes Patients

First Posted Date
2017-12-02
Last Posted Date
2021-02-21
Lead Sponsor
Profil Institut für Stoffwechselforschung GmbH
Target Recruit Count
20
Registration Number
NCT03359590
Locations
🇩🇪

Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany

Empagliflozin and Sympathetic Nerve Traffic

First Posted Date
2017-08-21
Last Posted Date
2020-07-14
Lead Sponsor
Profil Institut für Stoffwechselforschung GmbH
Target Recruit Count
75
Registration Number
NCT03254849
Locations
🇩🇪

Profil Institut für Stoffwechselforschung GmbH, Neuss, North Rhine-Westphalia, Germany

Validation of the Doubly Labelled Water Method in Subjects With Type 2 Diabetes Mellitus

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2015-08-10
Last Posted Date
2021-12-29
Lead Sponsor
Profil Institut für Stoffwechselforschung GmbH
Target Recruit Count
35
Registration Number
NCT02518581
Locations
🇩🇪

Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany

Effects of Linagliptin in Addition to Empagliflozin on Islet Cell Physiology

First Posted Date
2015-03-30
Last Posted Date
2016-02-24
Lead Sponsor
Profil Institut für Stoffwechselforschung GmbH
Target Recruit Count
89
Registration Number
NCT02401880
Locations
🇩🇪

Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany

🇩🇪

Profil Mainz GmbH & Co. KG, Mainz, Germany

Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion

Phase 1
Terminated
Conditions
Interventions
First Posted Date
2014-09-04
Last Posted Date
2018-10-17
Lead Sponsor
Profil Institut für Stoffwechselforschung GmbH
Target Recruit Count
109
Registration Number
NCT02231658
Locations
🇩🇪

St. Josef-Hospital, Universitätsklinik, Bochum, Germany

🇩🇪

Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany

A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1

Phase 2
Completed
Conditions
Interventions
First Posted Date
2014-08-20
Last Posted Date
2014-12-30
Lead Sponsor
Profil Institut für Stoffwechselforschung GmbH
Target Recruit Count
18
Registration Number
NCT02221323
Locations
🇩🇪

Profil Institut für Stoffwechselforschung GmbH, Neuss, NRW, Germany

A Trial Investigating the Influence of Injection Speed and Volume on the Perception of Subcutaneous Injection Pain

Phase 1
Completed
Conditions
Interventions
First Posted Date
2013-09-09
Last Posted Date
2014-12-30
Lead Sponsor
Profil Institut für Stoffwechselforschung GmbH
Target Recruit Count
80
Registration Number
NCT01937702
Locations
🇩🇪

Profil Mainz GmbH & Co. KG, Mainz, Rheinland-Pfalz, Germany

A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance Test

First Posted Date
2013-09-05
Last Posted Date
2017-11-07
Lead Sponsor
Profil Institut für Stoffwechselforschung GmbH
Target Recruit Count
34
Registration Number
NCT01936025
Locations
🇩🇪

Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany

Trial to Compare the Relative Pharmacodynamic Properties of Different Glucagon Dosages

Phase 1
Completed
Conditions
Interventions
First Posted Date
2013-08-05
Last Posted Date
2014-02-05
Lead Sponsor
Profil Institut für Stoffwechselforschung GmbH
Target Recruit Count
6
Registration Number
NCT01916265
Locations
🇩🇪

Profil Institut für Stoffwechselforschung GmbH, Neuss, NRW, Germany

© Copyright 2024. All Rights Reserved by MedPath